ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 1.9% of VRPX shares are held by financial institutions. JPMORGAN CHASE & CO is the top corporate investor, holding 0 shares valued at -. A 0% stake in Virpax Pharmaceuticals, Inc. is owned by the company. GEODE CAPITAL MANAGEMENT, LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the VRPX insiders holding of 3.72% of the stake in company, MACK ANTHONY P., Chief Executive Officer, holds the largest shares of 252.56K. SENDROW JERROLD, , is the second largest VRPX insider with ownership of 9.01K shares. FLOYD ERIC, , stands third with possession of 8.02K shares of that stake.